Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318214 | SCV000851484 | benign | Inborn genetic diseases | 2017-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001521122 | SCV001730392 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000884790 | SCV001859645 | benign | not provided | 2020-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000884790 | SCV004137988 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | CACNA1A: BS1, BS2 |